Braxia Scientific Corp C.BRAX

Alternate Symbol(s): BRAXF

Braxia Scientific Corp. is a Canada-based medical research and telemedicine company with a clinic that provide ketamine treatments for persons with depression and related disorders. Through its medical solutions, it intends to reduce the illness burden of brain-based disorders, such as major depressive disorder, among others. The Company is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. It seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. The Company has clinic operations in the Canadian cities of Mississauga, Kitchener-Waterloo, Ottawa and Montreal. Its subsidiary, Braxia Health, is engaged in offering rapid onset treatments to aid those suffering from several treatment-resistant conditions, such as depression and bipolar disorder.

CSE:BRAX - Post by User

Braxia Scientific Corp > News Release

<< Previous

Bullboard Posts

Next >>

Comment by cautiousguyon Feb 17, 2021 4:01pm

93 Views

Post# 32587474

RE:RE:RE:News Release

https://champignonbrands.com/news/champignon-brands-to-restate-financial-statements-and-mda-has-prepared-cse-listing-statement/

You can go to the CHAMPIGNON web site and read the release from RM yourself.

I take no joy in the implications of this. However, I take even less joy in the bulldip spewed but those that think wishing will make it so.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023